Obesity and its consequent metabolic syndrome have reached epidemic proportions in developed and some developing countries. It is estimated that, by 2025, around 70% of Australia’s adult population will be overweight, with 34% being obese. This poses a major risk factor for type II diabetes, cardiovascular disease, kidney disease, fertility, sleep disturbance and some forms of cancer, leading to a significant health care burden
Obesity and the Metabolic Syndrome will be the subject of a Making Connections symposium organized by Weizmann Australia and Monash University. The symposium will feature experts in this field from the Weizmann Institute, Israel, and Monash University and other Australian Universities and research institutes.
Plenary lectures will cover the epidemiology, causes (genetic, environmental and cultural), prevention and management of obesity. Symposia sessions will address the latest systems and molecular research in obesity and the metabolic syndrome, with a focus on CNS control and the pathogenesis of type II diabetes, myocardial infarction, stroke, vascular, renal and other obesity-related disorders.